| 000 | 01588 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515121550.0 | ||
| 264 | 0 | _c20080813 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2008.03020.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDovlatova, N L | |
| 245 | 0 | 0 |
_aThe reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJul 2008 |
||
| 300 |
_a1153-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Monophosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPiperazines _xmetabolism |
| 650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
| 650 | 0 | 4 | _aPlatelet Function Tests |
| 650 | 0 | 4 | _aPrasugrel Hydrochloride |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 | _aReceptors, Purinergic P2Y12 |
| 650 | 0 | 4 |
_aThiophenes _xmetabolism |
| 650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
| 700 | 1 | _aJakubowski, J A | |
| 700 | 1 | _aSugidachi, A | |
| 700 | 1 | _aHeptinstall, S | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 6 _gno. 7 _gp. 1153-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2008.03020.x _zAvailable from publisher's website |
| 999 |
_c17979538 _d17979538 |
||